1 November 2022 false Taxfiler 2024.5 12931778business:PrivateLimitedCompanyLtd2022-11-012023-10-31 129317782022-10-31 129317782022-11-012023-10-31 12931778business:AuditExemptWithAccountantsReport2022-11-012023-10-31 12931778business:FilletedAccounts2022-11-012023-10-31 129317782023-10-31 12931778business:Director12022-11-012023-10-31 12931778business:Director22022-11-012023-10-31 12931778business:Director32022-11-012023-10-31 12931778business:RegisteredOffice2022-11-012023-10-31 129317782022-10-31 12931778core:WithinOneYear2023-10-31 12931778core:WithinOneYear2022-10-31 12931778core:ShareCapitalcore:PreviouslyStatedAmount2023-10-31 12931778core:ShareCapitalcore:PreviouslyStatedAmount2022-10-31 12931778core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-10-31 12931778core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-10-31 12931778core:PreviouslyStatedAmount2023-10-31 12931778core:PreviouslyStatedAmount2022-10-31 12931778business:SmallEntities2022-11-012023-10-31 12931778countries:EnglandWales2022-11-012023-10-31 12931778core:FurnitureFittings2022-11-012023-10-31 12931778core:FurnitureFittings2022-10-31 12931778core:FurnitureFittings2023-10-31 12931778business:OrdinaryShareClass12022-11-012023-10-31 12931778business:OrdinaryShareClass12021-11-012022-10-31 129317782021-11-012022-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12931778 (England and Wales)
Rem Pharma Ltd Filleted accounts for the year ended 31 October 2023
Rem Pharma Ltd Filleted accounts Contents
Page
- 2 -
Rem Pharma Ltd Company Information for the year ended 31 October 2023
Directors
Mukeshbhai Chhaganlal Lad Ebrahim Farook Aziz Riaz Ahamed Abdul Sattar Omar
Company Number
12931778 (England and Wales)
Registered Office
4 Buckland Road Leicester LE5 0NT
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Rem Pharma Ltd Statement of financial position as at 31 October 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
15,000 
20,000 
Current assets
Inventories
- 
23,665 
Debtors
77 
9,065 
Cash at bank and in hand
71 
6,286 
148 
39,016 
Creditors: amounts falling due within one year
(36,418)
(66,351)
Net current liabilities
(36,270)
(27,335)
Net liabilities
(21,270)
(7,335)
Capital and reserves
Called up share capital
3 
3 
Profit and loss account
(21,273)
(7,338)
Shareholders' funds
(21,270)
(7,335)
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by
Ebrahim Farook Aziz Director Company Registration No. 12931778
- 4 -
Rem Pharma Ltd Notes to the Accounts for the year ended 31 October 2023
1
Statutory information
Rem Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12931778. The registered office is 4 Buckland Road, Leicester, LE5 0NT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% straight line
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
Rem Pharma Ltd Notes to the Accounts for the year ended 31 October 2023
4
Tangible fixed assets
Fixtures & fittings 
£ 
Cost or valuation
At cost 
At 1 November 2022
25,000 
At 31 October 2023
25,000 
Depreciation
At 1 November 2022
5,000 
Charge for the year
5,000 
At 31 October 2023
10,000 
Net book value
At 31 October 2023
15,000 
At 31 October 2022
20,000 
5
Inventories
2023 
2022 
£ 
£ 
Finished goods
- 
23,665 
- 
23,665 
6
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
VAT
77 
9,065 
7
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Trade creditors
1,347 
25,081 
Loans from directors
34,222 
40,722 
Accruals
849 
548 
36,418 
66,351 
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
3 Ordinary shares of £1 each
3 
3 
9
Average number of employees
During the year the average number of employees was 3 (2022: 3).
- 6 -